Abvc BioPharma
(NASDAQ) ABVC
Abvc BioPharma Financials at a Glance
Market Cap
$34.58M
Revenue (TTM)
-$795.95K
Net Income (TTM)
-$9.42M
EPS (TTM)
-$0.39
P/E Ratio
-3.42
Dividend
$0.00
Beta (Volatility)
0.81 (Low)
Dividend
$0.00
Beta (Volatility)
0.81 (Low)
Price
$1.43
Volume
261
Open
$1.38
Price
$1.43
Volume
261
Open
$1.38
Previous Close
$1.33
Daily Range
$1.38 - $1.43
52-Week Range
$0.88 - $5.48
Estimated Earnings Date
May 19, 2026
Dividend
$0.00
Beta (Volatility)
0.81 (Low)
Price
$1.43
Volume
261
Open
$1.38
Previous Close
$1.33
Daily Range
$1.38 - $1.43
52-Week Range
$0.88 - $5.48
Estimated Earnings Date
May 19, 2026
ABVC News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Abvc BioPharma
Industry
Biotechnology
Sector
Health CareEmployees
19
CEO
Uttam Yashwant Patil, PhD
Website
www.abvcpharma.comHeadquarters
Fremont, CA 94538, US
ABVC Financials
Key Financial Metrics (TTM)
Gross Margin
100.00%
Operating Margin
1108.95%
Net Income Margin
1183.83%
Return on Equity
-92.03%
Return on Capital
-49.03%
Return on Assets
-47.75%
Earnings Yield
-29.24%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$34.58M
Shares Outstanding
26.00M
Volume
261
Avg. Volume
120.56K
Financials (TTM)
Gross Profit
-$795.95K
Operating Income
-$8.83M
EBITDA
-$9.17M
Operating Cash Flow
-$3.34M
Capital Expenditure
$0.00
Free Cash Flow
-$3.34M
Cash & ST Invst.
$202.51K
Total Debt
$2.73M
Abvc BioPharma Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$0.00
N/A
Gross Margin
0.00%
N/A
Market Cap
$34.58M
N/A
Market Cap/Employee
$2.16M
N/A
Employees
16
N/A
Net Income
-$1.56M
-85.3%
EBITDA
-$1.55M
-155.0%
Quarterly Fundamentals
Total Cash
$202.51K
-75.4%
Total Debt
$2.73M
-8.7%
Accounts Receivable
$196.32K
-63.4%
Inventory
$0.00
-100.0%
Long Term Debt
$1.51M
+804.8%
Short Term Debt
$1.22M
-56.8%
Return on Assets
-47.75%
N/A
Return on Invested Capital
-61.56%
N/A
Free Cash Flow
-$894.24K
-65.7%
Operating Cash Flow
-$894.24K
-65.7%